Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,800 | 71,870 | 103,357 | 71,271 | 96,131 |
| Marketable Securities | 21,531 | 70,707 | 53,892 | 5,598 | 12,765 |
| TOTAL | $111,690 | $148,676 | $161,759 | $82,502 | $112,731 |
| Non-Current Assets | |||||
| PPE Net | 25,673 | 26,906 | 29,931 | 33,081 | 73,687 |
| Intangibles | 199,822 | 199,822 | 199,822 | 199,822 | 199,822 |
| Other Non-Current Assets | 36,408 | 41,486 | 43,920 | 46,240 | 59,230 |
| TOTAL | $261,903 | $268,214 | $273,673 | $279,143 | $332,739 |
| Total Assets | $373,593 | $416,890 | $435,432 | $361,645 | $445,470 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,123 | 1,669 | 1,858 | 2,270 | 989 |
| Accrued Expenses | 15,708 | 21,919 | 19,287 | 17,342 | 19,164 |
| Other current liabilities | 53,556 | 40,200 | N/A | N/A | N/A |
| TOTAL | $86,265 | $78,726 | $35,513 | $33,444 | $33,156 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 168,088 | 177,280 | 204,611 | 205,645 | 203,235 |
| TOTAL | $168,088 | $177,280 | $204,611 | $205,645 | $203,235 |
| Total Liabilities | $254,353 | $256,006 | $240,124 | $239,089 | $236,391 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 278,292 | 266,867 | 266,366 | 237,807 | 225,555 |
| Common Shares | 27 | 27 | 26 | 23 | 23 |
| Retained earnings | -1,896,226 | -1,849,016 | -1,790,191 | -1,748,039 | -1,654,239 |
| Other shareholders' equity | -2 | 28 | 21 | 0 | 0 |
| TOTAL | $119,240 | $160,884 | $195,308 | $122,556 | $209,079 |
| Total Liabilities And Equity | $373,593 | $416,890 | $435,432 | $361,645 | $445,470 |